In one paragraphArticle in Antimicrobial agents and chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
8 authors.
Tobias Funck *Department of Immunology and Infectious Disease, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.ORCID 0009-0003-8660-7451 Kerry McGowen *Department of Immunology and Infectious Disease, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.ORCID 0000-0002-8451-4070 Mark R SullivanDepartment of Immunology and Infectious Disease, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.ORCID 0000-0001-5765-0459 Samuel ZingaDepartment of Immunology and Infectious Disease, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Ian D WolfDepartment of Immunology and Infectious Disease, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Dennis NurjadiInstitute of Medical Microbiology, University of Lübeck & University Hospital Schleswig-Holstein Campus Lübeck, Lübeck, Germany.
Claudia M DenkingerDepartment of Infectious Disease and Tropical Medicine, Heidelberg University Hospital & German Center of Infection Research partner site, Heidelberg, Germany.ORCID 0000-0002-7216-7067 Eric J RubinDepartment of Immunology and Infectious Disease, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.ORCID 0000-0001-5120-962X Funding
Medical Scientist Training ProgramT32GM144273 · NIGMS · HARVARD MEDICAL SCHOOL · PI David Shumway Jones, Jacqueline A. Lees · 2022 to 2026
$14.7MMolecular mechanisms of inherent drug resistance in non-tuberculous mycobacteriaR01AI179642 · NIAID · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Jeremy Michael Rock, Eric J. Rubin · 2023 to 2026
$3.1MBoehringer Ingelheim Fonds MD FellowshipDamon Runyon Cancer Research Foundation DRG-2415-20NIGMS NIH HHS T32 GM144273NIGMS NIH HHS T32GM145407, T32GM007753, T32GM144273NIH HHS R01AI179642
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Anti-Bacterial AgentsDrug Resistance, BacterialLinezolidMycobacterium abscessusRibosomesATP-Binding Cassette TransportersBacterial ProteinsChloramphenicolHumansMacrolidesMicrobial Sensitivity TestsAnti-Bacterial AgentsATP-Binding Cassette TransportersBacterial ProteinsChloramphenicolLinezolidMacrolidesABC-F proteinsantibiotic resistanceantibioticsmycobacteriaMycobacterium abscessusribosomal protection
Identifiers
PMID41770215
PMCPMC13041422
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390